​

CME Group (CME) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CME Stock Forecast

CME Group (CME) stock forecast, based on 37 Wall Street analysts, predicts a 12-month average price target of $321.63, with a high of $367.00 and a low of $270.00. This represents a 5.11% increase from the last price of $305.98.

$200 $240 $280 $320 $360 $400 High: $367 Avg: $321.63 Low: $270 Last Closed Price: $305.98

CME Stock Rating

CME Group stock's rating consensus is Hold, based on 37 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (40.54%), 18 Hold (48.65%), 4 Sell (10.81%), and 0 Strong Sell (0.00%).

Hold
Total 37 0 4 18 15 Strong Sell Sell Hold Buy Strong Buy

CME Price Target Upside V Benchmarks

TypeNameUpside
StockCME Group5.11%
SectorFinancial Services Stocks 8.81%
IndustryFinancial Data & Stock Exchanges Stocks11.14%
IdeaBlockchain Stocks List17.53%
IdeaCrypto Stocks List49.65%

Price Target Trends

1M3M12M
# Anlaysts101128
Avg Price Target$321.40$316.73$317.96
Last Closing Price$305.98$305.98$305.98
Upside/Downside5.04%3.51%3.92%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 265351216
Sep, 264361216
Aug, 265441216
Jul, 264541216
Jun, 263371216
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 22, 2026Piper Sandler$330.00$295.7911.57%7.85%
Oct 22, 2026Daniel WeldenWells Fargo$333.00$295.7912.58%8.83%
Oct 22, 2026Michael CyprysMorgan Stanley$359.00$295.7921.37%17.33%
Oct 22, 2026CLSA$367.00$295.7924.07%19.94%
Oct 22, 2026Benjamin BudishBarclays$321.00$295.798.52%4.91%
Oct 14, 2026Daniel WeldenWells Fargo$315.00$278.0313.30%2.95%
Oct 09, 2026Morgan Stanley$337.00$276.4421.91%10.14%
Oct 07, 2026Barclays$281.00$270.184.00%-8.16%
Oct 05, 2026Alex KrammUBS$270.00$263.142.61%-11.76%
Oct 01, 2026Daniel WeldenWells Fargo$301.00$265.1013.54%-1.63%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 22, 2026Piper SandlerOverweightOverweighthold
Oct 14, 2026Wells FargoOverweightOverweighthold
Oct 09, 2026Morgan StanleyOverweightOverweighthold
Oct 05, 2026Cowen & Co.BuyBuyhold
Oct 05, 2026UBSNeutralNeutralhold
Oct 01, 2026Wells FargoOverweightinitialise
Aug 19, 2026Deutsche BankBuyHolddowngrade
Jul 23, 2026Morgan StanleyOverweightOverweighthold
Jul 23, 2026Bank of America SecuritiesUnderperformUnderperformhold
Jul 06, 2026UBSBuyBuyhold

Financial Forecast

EPS Forecast

$6 $7 $8 $9 $10 $11 $12 $13 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.30$7.41$8.87$9.69$11.18---
Avg Forecast$6.68$7.94$9.25$10.19$10.39$10.93$11.66$12.60
High Forecast$6.93$8.15$9.31$10.23$10.65$11.67$12.50$12.98
Low Forecast$6.42$7.59$9.21$10.15$10.09$9.82$10.82$12.04
Surprise %9.28%-6.68%-4.11%-4.91%7.60%---

Revenue Forecast

$5B $5B $6B $7B $7B $8B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.69B$5.02B$5.58B$6.13B$6.52B---
Avg Forecast$4.71B$5.02B$5.57B$6.11B$6.28B$6.57B$6.94B$7.39B
High Forecast$4.84B$5.13B$5.58B$6.12B$6.41B$6.59B$7.04B$7.56B
Low Forecast$4.57B$4.85B$5.55B$6.10B$6.15B$6.56B$6.84B$7.14B
Surprise %-0.35%-0.02%0.16%0.26%3.89%---

Net Income Forecast

$2B $3B $3B $4B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.64B$2.69B$3.23B$3.53B$4.04B---
Avg Forecast$2.58B$3.00B$3.19B$3.66B$3.73B$3.69B$4.19B$4.53B
High Forecast$3.09B$3.60B$3.82B$3.68B$3.83B$4.19B$4.49B$4.67B
Low Forecast$2.06B$2.40B$2.55B$3.65B$3.63B$3.53B$3.89B$4.33B
Surprise %2.35%-10.20%1.27%-3.75%8.52%---

CME Forecast FAQ

Is CME Group stock a buy?

CME Group stock has a consensus rating of Hold, based on 37 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 18 Hold, 4 Sell, and 0 Strong Sell, reflecting a consensus that CME Group is a neutral investment for most analysts.

What is CME Group's price target?

CME Group's price target, set by 37 Wall Street analysts, averages $321.63 over the next 12 months. The price target range spans from $270 at the low end to $367 at the high end, suggesting a potential 5.11% change from the previous closing price of $305.98.

How does CME Group stock forecast compare to its benchmarks?

CME Group's stock forecast shows a 5.11% upside, underperforming the average forecast for the financial services stocks sector (8.81%) and underperforming the financial data & stock exchanges stocks industry (11.14%), trailing the Blockchain Stocks List (17.53%) and Crypto Stocks List (49.65%) investment ideas.

What is the breakdown of analyst ratings for CME Group over the past three months?

  • October 2026: 31.25% Strong Buy, 18.75% Buy, 31.25% Hold, 6.25% Sell, 12.50% Strong Sell.
  • September 2026: 25.00% Strong Buy, 18.75% Buy, 37.50% Hold, 6.25% Sell, 12.50% Strong Sell.
  • August 2026: 31.25% Strong Buy, 25.00% Buy, 25.00% Hold, 6.25% Sell, 12.50% Strong Sell.

What is CME Group’s EPS forecast?

CME Group's average annual EPS forecast for its fiscal year ending in December 2026 is $10.93, marking a -2.24% decrease from the reported $11.18 in 2025. Estimates for the following years are $11.66 in 2027, and $12.6 in 2028.

What is CME Group’s revenue forecast?

CME Group's average annual revenue forecast for its fiscal year ending in December 2026 is $6.57B, reflecting a 0.83% increase from the reported $6.52B in 2025. The forecast for 2027 is $6.94B, and $7.39B for 2028.

What is CME Group’s net income forecast?

CME Group's net income forecast for the fiscal year ending in December 2026 stands at $3.69B, representing a -8.73% decrease from the reported $4.04B in 2025. Projections indicate $4.19B in 2027, and $4.53B in 2028.